Giacomo Bellani Selected Research

Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)

3/2024	Expiratory Muscle Activity Counteracts Positive End-Expiratory Pressure and Is Associated with Fentanyl Dose in Patients with Acute Respiratory Distress Syndrome.
11/2023	An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline.
1/2023	Timing of Prone Positioning During Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome.
1/2022	Individualized positive end-expiratory pressure guided by end-expiratory lung volume in early acute respiratory distress syndrome: study protocol for the multicenter, randomized IPERPEEP trial.
1/2022	Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies.
1/2021	Prone Positioning during Venovenous Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome. A Multicenter Cohort Study and Propensity-matched Analysis.
1/2021	Outcome of acute hypoxaemic respiratory failure: insights from the LUNG SAFE Study.
1/2020	Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: insights from the LUNG SAFE study.
1/2020	Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
1/2020	JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giacomo Bellani Research Topics

Disease

31	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2024 - 11/2005
23	COVID-19 02/2024 - 01/2020
23	Respiratory Insufficiency (Respiratory Failure) 02/2024 - 02/2012
20	Critical Illness (Critically Ill) 09/2023 - 07/2009
14	Lung Injury 01/2022 - 08/2005
13	Pneumonia (Pneumonitis) 10/2023 - 02/2011
10	Inflammation (Inflammations) 01/2021 - 08/2008
8	Sepsis (Septicemia) 02/2024 - 02/2009
8	Acute Lung Injury 01/2021 - 08/2008
7	Septic Shock (Toxic Shock Syndrome) 02/2024 - 04/2010
5	Fibrosis (Cirrhosis) 01/2021 - 12/2015
4	Infections 02/2024 - 10/2020
4	Edema (Dropsy) 11/2023 - 11/2005
4	Heart Arrest (Cardiac Arrest) 11/2023 - 01/2021
4	Pulmonary Edema 12/2022 - 11/2005
4	Atrophy 10/2020 - 09/2016
3	Hypoxia (Hypoxemia) 01/2024 - 09/2019
3	Wounds and Injuries (Trauma) 11/2023 - 01/2019
3	Heart Failure 01/2023 - 01/2020
3	Ventilator-Associated Pneumonia 01/2022 - 12/2019
3	Ventilator-Induced Lung Injury 10/2016 - 10/2011
2	Pulmonary Atelectasis 01/2024 - 12/2017
2	Brain Injuries (Brain Injury) 11/2023 - 06/2022
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 10/2020
2	Lung Diseases (Lung Disease) 03/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2022 - 06/2008
2	Pulmonary Hypertension 01/2022 - 01/2020
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2019
2	Neoplasms (Cancer) 01/2021 - 12/2016
1	Multiple Organ Failure (MODS) 02/2024
1	Respiratory Tract Diseases (Respiratory Tract Disease) 06/2022
1	Dyspnea (Shortness of Breath) 03/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Hemolysis 01/2022
1	Acidosis 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Shock 01/2022
1	Reperfusion Injury 01/2022
1	Coinfection 11/2021

Drug/Important Bio-Agent (IBA)

10	Oxygen (Dioxygen)IBA 10/2023 - 01/2017
10	AcidsIBA 01/2021 - 06/2008
4	CalciumIBA 01/2023 - 01/2021
4	AlbuminsIBA 11/2021 - 02/2015
4	fibrin fragment D (D-dimer)IBA 09/2021 - 12/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 08/2020
3	angiotensin I (1-7)IBA 01/2019 - 12/2015
3	Angiotensin IIIBA 01/2019 - 12/2015
3	Surface-Active Agents (Surfactants)IBA 02/2015 - 08/2005
3	PTX3 proteinIBA 10/2014 - 08/2008
3	Deoxyglucose (2 Deoxy D glucose)IBA 04/2012 - 07/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 01/2021
2	Simendan (Levosimendan)IBA 01/2023 - 01/2020
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2022 - 01/2022
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 08/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2014
2	Peptides (Polypeptides)IBA 01/2020 - 09/2016
2	Sevoflurane (Ultane)FDA LinkGeneric 05/2018 - 07/2009
2	GasesIBA 12/2017 - 06/2008
2	Hydrochloric Acid (Hydrogen Chloride)FDA Link 12/2017 - 02/2015
1	Fentanyl (Sublimaze)FDA LinkGeneric 03/2024
1	Neuromuscular Blocking AgentsIBA 11/2023
1	KynurenineIBA 11/2023
1	EnzymesIBA 11/2023
1	Essential Amino AcidsIBA 11/2023
1	Neuroprotective AgentsIBA 11/2023
1	Tryptophan (L-Tryptophan)FDA Link 11/2023
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2022
1	VaccinesIBA 10/2022
1	mRNA VaccinesIBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	Blood Substitutes (Artificial Blood)IBA 06/2022
1	Carbon MonoxideIBA 03/2022
1	NitrogenIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	SteroidsIBA 01/2022
1	Vasodilator Agents (Vasodilators)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 11/2021
1	Immunoglobulin A (IgA)IBA 11/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2021

Therapy/Procedure

39	Artificial Respiration (Mechanical Ventilation) 02/2024 - 05/2011
17	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 03/2024 - 07/2013
12	Extracorporeal Membrane Oxygenation 01/2024 - 10/2011
11	Therapeutics 02/2024 - 06/2008
9	Noninvasive Ventilation 01/2024 - 02/2016
8	Continuous Positive Airway Pressure 01/2024 - 04/2009
7	Critical Care (Surgical Intensive Care) 09/2023 - 07/2017
5	Mechanical Ventilators (Ventilator) 01/2020 - 09/2013
4	Airway Management 01/2023 - 01/2021
3	Length of Stay 01/2022 - 01/2019
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 06/2022 - 01/2022
2	Cardiopulmonary Resuscitation (CPR) 01/2022 - 01/2021
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021 - 01/2019
2	Cannula 09/2020 - 01/2017
2	Interactive Ventilatory Support 09/2014 - 02/2012
2	Glycemic Control 04/2010 - 02/2009
1	Emergency Treatment 10/2023
1	Analgesia 01/2022
1	Anesthesia 01/2022
1	Resuscitation 01/2022